Posted in | News | Materials Science

Daylight Solutions Receives Microscopy Innovation and R&D 100 Finalist Awards

Following a series of impressive awards in 2014, Daylight Solutions, Inc., the world’s leader in mid-infrared detection and imaging solutions, announced two new prestigious awards for their Spero™ microscope.

 

 

Spero was awarded the 6th Annual Microscopy Today Innovation Award and was also named a finalist in the 2015 R&D 100 Awards taking place later this year.

The winners of the Microscopy Today Innovation Awards were announced last week at the Microscopy and Microanalysis Conference in Portland, OR. The awards are hosted by the editors of Microscopy Today magazine and recognize outstanding innovations across a broad range of microscopy techniques and products.

Daylight Solutions’ Spero was recognized for enabling real-time chemical imaging for the first time in a mid-infrared microscope.  Spero was selected from an impressive list of finalists including Carl Zeiss and others.

Spero was also recently announced as a finalist in the 2015 R&D 100 Awards. The R&D 100 Awards, often described as “The Oscars of Invention” are awarded to the top technology products of the year across industry, academia, and government-sponsored research.  The final winners will be announced at an awards gala in November.

These recent awards follow a remarkable set of awards granted to Spero following its launch in March of 2014. Spero was awarded the 2014 Innovation Award Grand Prize at CLEO, the Conference for Lasers and Electro-Optics, and was also named “Top Product” at Pittcon 2014 byInstrument Business Outlook at Strategic Directions International.

Spero is the world’s first laser-based infrared microscopy platform and represents a true breakthrough in high-performance spectral imaging. Spectral imaging allows a user to visualize the varying chemical content across a sample and Spero provides this data with higher spatial resolution, larger fields of view, and dramatically faster than existing instruments. And for the first time, chemical imaging can be done in real-time with Spero’s innovative Live Mode.  Spero provides groundbreaking chemical imaging capabilities for biomedical and materials research.

For more information on the Spero microscope, please visit: www.daylightsolutions.com/spero

About Daylight Solutions

Daylight Solutions develops molecular detection and imaging systems for use in scientific research, life sciences, industrial, and defense applications. The company is the world leader in mid-infrared laser based solutions, with a line of broadly tunable and fixed wavelength laser sources, sensors, and microscopes that utilize mid-infrared spectroscopy and imaging.

The statements contained in this news release are not purely historical and contain forward looking information and statements. These include statements regarding the Company's expectations, intentions, or strategies regarding future matters. All forward-looking statements included in this press release are based on information available to the Company on the date released.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Daylight Solutions Inc.. (2023, March 29). Daylight Solutions Receives Microscopy Innovation and R&D 100 Finalist Awards. AZoM. Retrieved on April 28, 2024 from https://www.azom.com/news.aspx?newsID=44316.

  • MLA

    Daylight Solutions Inc.. "Daylight Solutions Receives Microscopy Innovation and R&D 100 Finalist Awards". AZoM. 28 April 2024. <https://www.azom.com/news.aspx?newsID=44316>.

  • Chicago

    Daylight Solutions Inc.. "Daylight Solutions Receives Microscopy Innovation and R&D 100 Finalist Awards". AZoM. https://www.azom.com/news.aspx?newsID=44316. (accessed April 28, 2024).

  • Harvard

    Daylight Solutions Inc.. 2023. Daylight Solutions Receives Microscopy Innovation and R&D 100 Finalist Awards. AZoM, viewed 28 April 2024, https://www.azom.com/news.aspx?newsID=44316.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.